175 related articles for article (PubMed ID: 37455764)
1. Illuminating the role of lncRNAs ROR and MALAT1 in cancer stemness state of anaplastic thyroid cancer: An exploratory study.
Mahdiannasser M; Khazaei S; Akhavan Rahnama M; Soufi-Zomorrod M; Soutodeh F; Parichehreh-Dizaji S; Rakhsh-Khorshid H; Samimi H; Haghpanah V
Noncoding RNA Res; 2023 Sep; 8(3):451-458. PubMed ID: 37455764
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
[TBL] [Abstract][Full Text] [Related]
3. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract][Full Text] [Related]
4. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
5. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
[TBL] [Abstract][Full Text] [Related]
6. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.
Carina V; Zito G; Pizzolanti G; Richiusa P; Criscimanna A; Rodolico V; Tomasello L; Pitrone M; Arancio W; Giordano C
Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671
[TBL] [Abstract][Full Text] [Related]
7. Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs.
Hardin H; Helein H; Meyer K; Robertson S; Zhang R; Zhong W; Lloyd RV
Lab Invest; 2018 Sep; 98(9):1133-1142. PubMed ID: 29967342
[TBL] [Abstract][Full Text] [Related]
8. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.
Haghpanah V; Fallah P; Tavakoli R; Naderi M; Samimi H; Soleimani M; Larijani B
Tumour Biol; 2016 Jan; 37(1):1299-308. PubMed ID: 26289851
[TBL] [Abstract][Full Text] [Related]
9. Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem Cells.
Bozorg-Ghalati F; Hedayati M; Dianatpour M; Azizi F; Mosaffa N; Mehrabani D
Asian Pac J Cancer Prev; 2017 Aug; 18(8):2287-2291. PubMed ID: 28843268
[TBL] [Abstract][Full Text] [Related]
10. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
Kocdor MA; Cengiz H; Ates H; Kocdor H
Anticancer Agents Med Chem; 2019; 19(15):1887-1898. PubMed ID: 31584382
[TBL] [Abstract][Full Text] [Related]
12. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C
PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156
[TBL] [Abstract][Full Text] [Related]
13. CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin.
Friedman S; Lu M; Schultz A; Thomas D; Lin RY
PLoS One; 2009; 4(4):e5395. PubMed ID: 19404394
[TBL] [Abstract][Full Text] [Related]
14. M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway.
Lv J; Liu C; Chen FK; Feng ZP; Jia L; Liu PJ; Yang ZX; Hou F; Deng ZY
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184083
[TBL] [Abstract][Full Text] [Related]
15. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability.
Wang J; Shao F; Yang Y; Wang W; Yang X; Li R; Cheng H; Sun S; Feng X; Gao Y; He J; Lu Z
Cancer Commun (Lond); 2022 Oct; 42(10):1008-1027. PubMed ID: 35975322
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA ROR Regulates Proliferation, Invasion, and Stemness of Gastric Cancer Stem Cell.
Wang S; Liu F; Deng J; Cai X; Han J; Liu Q
Cell Reprogram; 2016 Oct; 18(5):319-326. PubMed ID: 27602437
[TBL] [Abstract][Full Text] [Related]
18. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
19. The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression.
Heiden KB; Williamson AJ; Doscas ME; Ye J; Wang Y; Liu D; Xing M; Prinz RA; Xu X
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2178-87. PubMed ID: 25078145
[TBL] [Abstract][Full Text] [Related]
20. Long intergenic non-coding RNA, regulator of reprogramming (LINC-ROR) over-expression predicts poor prognosis in renal cell carcinoma.
Fawzy MS; Toraih EA; El-Wazir A; Hosny MM; Badran DI; El Kelish A
Arch Med Sci; 2021; 17(4):1016-1027. PubMed ID: 34336029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
